Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8,182 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.
Gong WJ, Peng JB, Yin JY, Li XP, Zheng W, Xiao L, Tan LM, Xiao D, Chen YX, Li X, Zhou HH, Liu ZQ. Gong WJ, et al. Acta Pharmacol Sin. 2017 Apr;38(4):581-590. doi: 10.1038/aps.2016.164. Epub 2017 Mar 6. Acta Pharmacol Sin. 2017. PMID: 28260796 Free PMC article.
The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
Xiao D, Guo Y, Li X, Yin JY, Zheng W, Qiu XW, Xiao L, Liu RR, Wang SY, Gong WJ, Zhou HH, Liu ZQ. Xiao D, et al. Int J Endocrinol. 2016;2016:4350712. doi: 10.1155/2016/4350712. Epub 2016 Feb 10. Int J Endocrinol. 2016. PMID: 26977146 Free PMC article.
Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients.
Yin JY, Li X, Li XP, Xiao L, Zheng W, Chen J, Mao CX, Fang C, Cui JJ, Guo CX, Zhang W, Gao Y, Zhang CF, Chen ZH, Zhou H, Zhou HH, Liu ZQ. Yin JY, et al. Cancer Lett. 2016 Jul 10;377(1):65-73. doi: 10.1016/j.canlet.2016.04.029. Epub 2016 Apr 25. Cancer Lett. 2016. PMID: 27126360
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer.
Li L, Zhu T, Gao YF, Zheng W, Wang CJ, Xiao L, Huang MS, Yin JY, Zhou HH, Liu ZQ. Li L, et al. Int J Mol Sci. 2016 May 31;17(6):839. doi: 10.3390/ijms17060839. Int J Mol Sci. 2016. PMID: 27258253 Free PMC article. Review.
Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients.
Zou T, Yin J, Zheng W, Xiao L, Tan L, Chen J, Wang Y, Li X, Qian C, Cui J, Zhang W, Zhou H, Liu Z. Zou T, et al. Cancer Chemother Pharmacol. 2016 Aug;78(2):249-58. doi: 10.1007/s00280-016-3072-0. Epub 2016 Jun 14. Cancer Chemother Pharmacol. 2016. PMID: 27299748 Clinical Trial.
Circulating resistin levels and obesity-related cancer risk: A meta-analysis.
Gong WJ, Zheng W, Xiao L, Tan LM, Song J, Li XP, Xiao D, Cui JJ, Li X, Zhou HH, Yin JY, Liu ZQ. Gong WJ, et al. Oncotarget. 2016 Sep 6;7(36):57694-57704. doi: 10.18632/oncotarget.11034. Oncotarget. 2016. PMID: 27509174 Free PMC article.
Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
Shi YX, Zhu T, Zou T, Zhuo W, Chen YX, Huang MS, Zheng W, Wang CJ, Li X, Mao XY, Zhang W, Zhou HH, Yin JY, Liu ZQ. Shi YX, et al. Oncotarget. 2016 Dec 20;7(51):85235-85243. doi: 10.18632/oncotarget.13252. Oncotarget. 2016. PMID: 27835911 Free PMC article.
[CT-based estimation of liver function using arterial enhancement fraction in liver cirrhosis patients].
Rong P, Feng Z, Guo R, Zheng W, Hu Y, Li J, Wang W. Rong P, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 May 28;44(5):469-476. doi: 10.11817/j.issn.1672-7347.2019.05.001. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31303608 Chinese.
Establishing Prediction Model of Antiepileptic Drugs Response using Data Mining Approach.
Yin JY, Qu J, Mao CX, Li X, Mao XY, Xiao B, Xiao L, Zheng W, Zhou HH, Liu ZQ. Yin JY, et al. CNS Neurosci Ther. 2016 Oct;22(10):860-2. doi: 10.1111/cns.12599. Epub 2016 Aug 15. CNS Neurosci Ther. 2016. PMID: 27527827 Free PMC article. No abstract available.
8,182 results
Jump to page